Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzothiazole | HCID 7222 | — |
| Reactant | Methyl 2-chloro-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylate | HCID 86667203 | — |
| Reactant | HCID 178476685 | HCID 178476685 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Product | HCID 70664862 | HCID 70664862 | 9.4% |
Reaction Steps
Into a 10-mL sealed was placed methyl 2-chloro-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylate (400 mg, 1.36 mmol), 1,3-benzothiazole (368 mg, 2.72 mmol), Pd(PPh3)4 (80 mg, 0.06 mmol) and AcOK (272 mg, 2.72 mmol) under nitrogen atmosphere. After stirring 4 h at 150° C., the reaction mixture was purified by silica gel column chromatography eluting with 10% ethyl acetate in petroleum ether to afford methyl 2-(1,3-benzothiazol-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylate as a light yellow solid (50 mg, 9.4%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08912188B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-7a29b978fa904d7cae00e6fc5d9ba8f9 |
|---|
| Source note | uspto-grants-2014_12 |
|---|